30 research outputs found
Recommended from our members
Long-Term and Inter-annual Mass Changes in the Iceland Ice Cap Determined From GRACE Gravity Using Slepian Functions
The Gravity Recovery and Climate Experiment (GRACE) satellites have measured anomalies in the Earth's time-variable gravity field since 2002, allowing for the measurement of the melting of glaciers due to climate change. Many techniques used with GRACE data have difficulty constraining mass change in small regions, such as Iceland, often requiring broad averaging functions in order to capture trends. These techniques also capture data from nearby regions, causing signal leakage. Alternatively, Slepian functions may solve this problem by optimally concentrating data both in the spatial domain (e.g., Iceland) and spectral domain (i.e., the bandwidth of the data). We use synthetic experiments to show that Slepian functions can capture trends over Iceland without meaningful leakage and influence from ice changes in Greenland. We estimate a mass change over Iceland from GRACE data of approximately -9.3 ± 1.0 Gt/yr between March 2002 and November 2016, with an acceleration of 1.1 ± 0.5 Gt/yr2.NASA Space Grant Internship at the University of Arizona; TRIFF-WEES program at the University of ArizonaOpen access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]
Recommended from our members
The Effects of Lithospheric Thickness Variations On the Dynamics of the Earth's Upper Mantle
The first-order cause of lithospheric motion at the Earth's surface is convection within the mantle. I examine how lithospheric thickness variations affect the dynamics of the upper mantle and the impact they can have on the surface in a series of analytical and numerical experiments. Perturbations to the thickness of mantle lithosphere from horizontal shortening are considered as Rayleigh-Taylor instabilities. This deformation is considered in the context of the Sierra Nevada range in California, where lithosphere may be downwelling and the lower crust may be weak. Lithospheric instabilities are also considered in relation to intracontinental magmatism, several hundred kilometers away from active plate boundaries or rift zones. In cratonic regions, where lithosphere can be several times thicker than the global average, the motion of continental keels cause pressure gradients within the upper mantle. Constraints on upper mantle viscosity can be obtained by considering the dynamic gravity effects from these induced pressure gradients. At subduction zones the motion of subducted lithosphere within the mantle is examined along with its effects on the pressure field and dip angle evolution. Overall, lithosphere of varying thickness can have significant regional impacts on Earth's near surface dynamics, which occur against the background first-order dynamics
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study
Background: Mantle-cell lymphoma is an aggressive B-cell lymphoma with a poor prognosis. Both ibrutinib and temsirolimus have shown single-agent activity in patients with relapsed or refractory mantle-cell lymphoma. We undertook a phase 3 study to assess the efficacy and safety of ibrutinib versus temsirolimus in relapsed or refractory mantle-cell lymphoma.
Methods: This randomised, open-label, multicentre, phase 3 clinical trial enrolled patients with relapsed or refractory mantle-cell lymphoma confirmed by central pathology in 21 countries who had received one or more rituximab-containing treatments. Patients were stratified by previous therapy and simplified mantle-cell lymphoma international prognostic index score, and were randomly assigned with a computer-generated randomisation schedule to receive daily oral ibrutinib 560 mg or intravenous temsirolimus (175 mg on days 1, 8, and 15 of cycle 1; 75 mg on days 1, 8, and 15 of subsequent 21-day cycles). Randomisation was balanced by using randomly permuted blocks. The primary efficacy endpoint was progression-free survival assessed by a masked independent review committee with the primary hypothesis that ibrutinib compared with temsirolimus significantly improves progression-free survival. The analysis followed the intention-to-treat principle. The trial is ongoing and is registered with ClinicalTrials.gov (number NCT01646021) and with the EU Clinical Trials Register, EudraCT (number 2012-000601-74).
Findings: Between Dec 10, 2012, and Nov 26, 2013, 280 patients were randomised to ibrutinib (n=139) or temsirolimus (n=141). Primary efficacy analysis showed significant improvement in progression-free survival (p<0.0001) for patients treated with ibrutinib versus temsirolimus (hazard ratio 0.43 [95% CI 0.32-0.58]; median progression-free survival 14.6 months [95% CI 10.4-not estimable] vs 6.2 months [4.2-7.9], respectively). Ibrutinib was better tolerated than temsirolimus, with grade 3 or higher treatment-emergent adverse events reported for 94 (68%) versus 121 (87%) patients, and fewer discontinuations of study medication due to adverse events for ibrutinib versus temsirolimus (9 [6%] vs 36 [26%]).
Interpretation: Ibrutinib treatment resulted in significant improvement in progression-free survival and better tolerability versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma. These data lend further support to the positive benefit-risk ratio for ibrutinib in relapsed or refractory mantle-cell lymphoma
Recommended from our members
Accelerating changes in ice mass within Greenland, and the ice sheet's sensitivity to atmospheric forcing
The recent deglaciation of Greenland is a response to both oceanic and atmospheric forcings. From 2000 to 2010, ice loss was concentrated in the southeast and northwest margins of the ice sheet, in large part due to the increasing discharge of marine-terminating outlet glaciers, emphasizing the importance of oceanic forcing. However, the largest sustained (∼10 years) acceleration detected by Gravity Recovery and Climate Experiment (GRACE) occurred in southwest Greenland, an area largely devoid of such glaciers. The sustained acceleration and the subsequent, abrupt, and even stronger deceleration were mostly driven by changes in air temperature and solar radiation. Continued atmospheric warming will lead to southwest Greenland becoming a major contributor to sea level rise
Mass balance of the Greenland Ice Sheet from 1992 to 2018
In recent decades, the Greenland Ice Sheet has been a major contributor to global sea-level rise1,2, and it is expected to be so in the future3. Although increases in glacier flow4–6 and surface melting7–9 have been driven by oceanic10–12 and atmospheric13,14 warming, the degree and trajectory of today’s imbalance remain uncertain. Here we compare and combine 26 individual satellite measurements of changes in the ice sheet’s volume, flow and gravitational potential to produce a reconciled estimate of its mass balance. Although the ice sheet was close to a state of balance in the 1990s, annual losses have risen since then, peaking at 335 ± 62 billion tonnes per year in 2011. In all, Greenland lost 3,800 ± 339 billion tonnes of ice between 1992 and 2018, causing the mean sea level to rise by 10.6 ± 0.9 millimetres. Using three regional climate models, we show that reduced surface mass balance has driven 1,971 ± 555 billion tonnes (52%) of the ice loss owing to increased meltwater runoff. The remaining 1,827 ± 538 billion tonnes (48%) of ice loss was due to increased glacier discharge, which rose from 41 ± 37 billion tonnes per year in the 1990s to 87 ± 25 billion tonnes per year since then. Between 2013 and 2017, the total rate of ice loss slowed to 217 ± 32 billion tonnes per year, on average, as atmospheric circulation favoured cooler conditions15 and as ocean temperatures fell at the terminus of Jakobshavn Isbræ16. Cumulative ice losses from Greenland as a whole have been close to the IPCC’s predicted rates for their high-end climate warming scenario17, which forecast an additional 50 to 120 millimetres of global sea-level rise by 2100 when compared to their central estimate
Mass balance of the Greenland and Antarctic ice sheets from 1992 to 2020
Ice losses from the Greenland and Antarctic ice sheets have accelerated since the 1990s, accounting for a significant increase in the global mean sea level. Here, we present a new 29-year record of ice sheet mass balance from 1992 to 2020 from the Ice Sheet Mass Balance Inter-comparison Exercise (IMBIE). We compare and combine 50 independent estimates of ice sheet mass balance derived from satellite observations of temporal changes in ice sheet flow, in ice sheet volume, and in Earth's gravity field. Between 1992 and 2020, the ice sheets contributed 21.0±1.9g€¯mm to global mean sea level, with the rate of mass loss rising from 105g€¯Gtg€¯yr-1 between 1992 and 1996 to 372g€¯Gtg€¯yr-1 between 2016 and 2020. In Greenland, the rate of mass loss is 169±9g€¯Gtg€¯yr-1 between 1992 and 2020, but there are large inter-annual variations in mass balance, with mass loss ranging from 86g€¯Gtg€¯yr-1 in 2017 to 444g€¯Gtg€¯yr-1 in 2019 due to large variability in surface mass balance. In Antarctica, ice losses continue to be dominated by mass loss from West Antarctica (82±9g€¯Gtg€¯yr-1) and, to a lesser extent, from the Antarctic Peninsula (13±5g€¯Gtg€¯yr-1). East Antarctica remains close to a state of balance, with a small gain of 3±15g€¯Gtg€¯yr-1, but is the most uncertain component of Antarctica's mass balance. The dataset is publicly available at 10.5285/77B64C55-7166-4A06-9DEF-2E400398E452 (IMBIE Team, 2021)
Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis
Dysbiosis resulting in gut-microbiome alterations with reduced butyrate production are thought to disrupt intestinal immune homeostasis and promote complex immune disorders. However, whether and how dysbiosis develops before the onset of overt pathology remains poorly defined. Interleukin-15 (IL-15) is upregulated in distressed tissue and its overexpression is thought to predispose susceptible individuals to and have a role in the pathogenesis of celiac disease and inflammatory bowel disease (IBD). Although the immunological roles of IL-15 have been largely studied, its potential impact on the microbiota remains unexplored. Analysis of 16S ribosomal RNA-based inventories of bacterial communities in mice overexpressing IL-15 in the intestinal epithelium (villin-IL-15 transgenic (v-IL-15tg) mice) shows distinct changes in the composition of the intestinal bacteria. Although some alterations are specific to individual intestinal compartments, others are found across the ileum, cecum and feces. In particular, IL-15 overexpression restructures the composition of the microbiota with a decrease in butyrate-producing bacteria that is associated with a reduction in luminal butyrate levels across all intestinal compartments. Fecal microbiota transplant experiments of wild-type and v-IL-15tg microbiota into germ-free mice further indicate that diminishing butyrate concentration observed in the intestinal lumen of v-IL-15tg mice is the result of intrinsic alterations in the microbiota induced by IL-15. This reconfiguration of the microbiota is associated with increased susceptibility to dextran sodium sulfate-induced colitis. Altogether, this study reveals that IL-15 impacts butyrate-producing bacteria and lowers butyrate levels in the absence of overt pathology, which represent events that precede and promote intestinal inflammatory diseases
Recommended from our members
Ice mass loss in Greenland, the Gulf of Alaska, and the Canadian Archipelago: Seasonal cycles and decadal trends
Over the past several decades mountain glaciers and ice caps have been significant contributors to sea level rise. Here we estimate the ice mass changes in the Canadian Archipelago, the Gulf of Alaska, and Greenland since 2003 by analyzing time‐varying gravimetry data from the Gravity Recovery and Climate Experiment. Prior to 2013, interannual ice mass variability in the Gulf of Alaska and in regions around Greenland remains within the average estimated over the whole data span. Beginning in summer 2013, ice mass in regions around Greenland departs positively from its long‐term trend. Over Greenland this anomaly reached almost 500 Gt through the end of 2014. Overall, long‐term ice mass loss from Greenland and the Canadian Archipelago continues to accelerate, while losses around the Gulf of Alaska region continue but remain steady with no significant acceleration